Study: Accutane does increase IBD risk

08/15/2006 | Sydney Morning Herald (Australia), The

New research confirms what had been expected -- the 24-year-old acne drug Accutane appears to increase the risk of inflammatory bowel diseases. The study authors surveyed isotretinoin-associated IBD reports filed with the U.S. FDA and found 85 cases in one recent five-year period.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA